Evaluation of the CIHR HIV/AIDS and STBBI Research Initiative - Management Response and Action Plan (MRAP)
Introduction
- This MRAP is in response to the CIHR HIV/AIDS and STBBI Research Initiative evaluation and recommendations conducted in 2024, by CIHR’s Evaluation Unit within the Office of Internal Audit.
- CIHR Research Program Portfolio will be responsible for the implementation of the MRAP, with scientific support from the Institute of Infection and Immunity (III).
Recommendation 1
CIHR should continue to lead the Government of Canada’s research response to HIV/AIDS and STBBI to address ongoing and emerging research needs.
Management Response: Agree
Action and Rationale | Expected completion/implementation date | Date of Management Action Plan Action | Responsibility for Action |
---|---|---|---|
In line with priorities identified in the 'Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024-2030' and the level of support provided, CIHR will continue to lead the Government of Canada’s research response to HIV/AIDS and STBBI. | 2025-26 (Ongoing) | May 2025 |
Vice-President, Research Programs Director General, Initiative Management and Institute Support |
Recommendation 2
CIHR should update the RI funding mechanisms to minimize application barriers and enhance the capacity of early career researchers and populations disproportionately impacted by HIV/AIDS and STBBI to access RI funding.
Management Response: Agree
Action and Rationale | Expected completion/implementation date | Date of Management Action Plan Action | Responsibility for Action |
---|---|---|---|
In line with the CIHR HIV/AIDS and STBBI Research Initiative Strategic Plan (2022- 2027), CIHR will continue to:
|
2026/27 (ongoing) | May 2025 |
Vice-President, Research Programs Director General, Initiative Management and Institute Support Director General, Program Design and Delivery |
Recommendation 3
CIHR should strengthen engagement with government and non-governmental organizations to:
- Advance research and build capacity for priority populations disproportionately impacted by HIV/AIDS and STBBI.
- Coordinate knowledge mobilization of RI-funded research to maximize its use by healthcare and community organizations.
Management Response: Agree
Action and Rationale | Expected completion/implementation date | Date of Management Action Plan Action | Responsibility for Action |
---|---|---|---|
|
2026/27 (ongoing) | September 2025 |
Vice-President, Research Programs Director General, Initiative Management and Institute Support |
|
2026/27 (ongoing) | September 2025 |
Vice-President, Research Programs Director General, Initiative Management and Institute Support |
Recommendation 4
CIHR should improve the availability and monitoring of:
- Operating and maintenance expenditure data, specifically direct salary costs.
- Performance reporting of RI-funded research to better inform decision-making and communicate impact.
Management Response: Agree
Action and Rationale | Expected completion/implementation date | Date of Management Action Plan Action | Responsibility for Action |
---|---|---|---|
|
December 2025 | May 2025 |
Vice-President, Research Programs Director General, Initiative Management and Institute Support In collaboration with: Chief Financial Officer |
|
December 2025 | May 2025 |
Vice-President, Research Programs Director General, Initiative Management and Institute Support |
- Date modified: